Adult patients with uveitis associated with juvenile idiopathic arthritis: a retrospective review

Can J Ophthalmol. 2017 Oct;52(5):458-462. doi: 10.1016/j.jcjo.2017.01.011. Epub 2017 Mar 18.

Abstract

Objective: To describe clinical characteristics and outcomes of adults with uveitis associated with juvenile idiopathic arthritis (JIA).

Methods: Retrospective chart review from 2001 to 2014 of adult patients with JIA and follow-up ≥2 months. Outcome measures included visual acuity, intraocular pressure (IOP), inflammation grade, ocular findings/complications, immunosuppressive therapies, and surgeries.

Results: Nineteen patients were included (95% female, 84% bilateral uveitis, 47% anterior uveitis). Mean (SD) ages at presentation and JIA diagnosis were 25.6 (7.8) years and 8.9 (5.6) years, respectively. Visual acuity and IOP did not significantly change throughout the study. Mean (SD) presenting inflammation grade was significantly decreased at 6 and 12 months. Fifteen (79%) patients were on topical medications, and 17 (89%) were on systemic immunosuppression. Two (12%) patients developed side effects requiring medication cessation.

Conclusion: Uveitis associated with JIA may extend into adulthood despite the use of topical medications and/or systemic immunosuppression and result in significant ocular morbidity, including the need for surgical intervention.

Publication types

  • Review

MeSH terms

  • Adult
  • Arthritis, Juvenile / complications*
  • Arthritis, Juvenile / diagnosis
  • Arthritis, Juvenile / drug therapy
  • Arthritis, Juvenile / physiopathology
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Intraocular Pressure / physiology
  • Male
  • Ophthalmologic Surgical Procedures
  • Retrospective Studies
  • Risk Factors
  • Tonometry, Ocular
  • Uveitis / diagnosis
  • Uveitis / drug therapy
  • Uveitis / etiology*
  • Uveitis / physiopathology
  • Visual Acuity / physiology
  • Young Adult

Substances

  • Immunosuppressive Agents